Gary A. Lyons, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 23,140 shares at $150.43 ($3.5M) on 2024-08-13, disclosed to the SEC on 2024-08-15.
Scheduled sale ($3.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.43 | 11,570 | $1.7M | 50.0% |
| 2 | $150.43 | 11,570 | $1.7M | 50.0% |
| Total | $150.43 avg | 23,140 | $3.5M | 100% |
| Filing → |
| NBIX | SELL | 2025-12-04 | $2.3M | — | Filing → |
| TVTX | SELL | 2024-10-04 | $1.2M | — | Filing → |
| NBIX | SELL | 2024-07-18 | $279K | — | Filing → |